55 year old male presents with hyperpigmentation, nail atrophy and reversible hair loss. Patient also have hamaomatous colon polyps. Diagnosis is ?
**Core Concept**
The patient's symptoms suggest a systemic disorder characterized by hyperpigmentation, nail atrophy, reversible hair loss, and the presence of hamartomatous colon polyps. This constellation of findings is indicative of a genetic disorder that affects multiple organ systems.
**Why the Correct Answer is Right**
The patient's presentation is consistent with Peutz-Jeghers Syndrome (PJS), a rare autosomal dominant disorder caused by mutations in the STK11 (LKB1) gene. The STK11 gene is a tumor suppressor that regulates cell growth and division. Mutations in this gene lead to the development of hamartomatous polyps in the colon, small intestine, and other organs. The polyps are associated with an increased risk of gastrointestinal cancer and other malignancies. The skin and hair manifestations in PJS are thought to result from the same genetic defect, leading to increased sensitivity to hormones and growth factors.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately describe the clinical presentation or genetic basis of Peutz-Jeghers Syndrome.
* **Option B:** This option is incorrect because it suggests a different diagnosis, such as Cowden syndrome, which is characterized by hamartomatous polyps and other distinct clinical features.
* **Option C:** This option is incorrect because it implies a different genetic disorder, such as Familial Adenomatous Polyposis (FAP), which is caused by mutations in the APC gene.
* **Option D:** This option is incorrect because it suggests a benign condition, whereas Peutz-Jeghers Syndrome is a genetic disorder with significant implications for cancer risk.
**Clinical Pearl / High-Yield Fact**
Peutz-Jeghers Syndrome is associated with an increased risk of gastrointestinal cancer, particularly small intestine cancer, as well as breast, ovarian, and other malignancies. Patients with PJS should undergo regular screening for these cancers, starting at a young age.
**Correct Answer:** B.